Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute nonlymphocytic leukemia

N L Kobrinsky, L L Robison, M E Nesbit

    Pediatric Clinics of North America
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    New chemotherapy drugs and combination therapies have improved cancer remission rates. However, effective maintenance therapy remains a challenge for long-term survival in patients with this disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

    AJNR. American journal of neuroradiology·2018
    Same author

    Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study.

    Journal of cancer survivorship : research and practice·2016
    Same author

    A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

    Nature communications·2014
    Same author

    Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study.

    Journal of cancer survivorship : research and practice·2014
    Same author

    Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.

    Pediatric blood & cancer·2014
    Same journal

    Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

    Pediatric clinics of North America·2026
    Same journal

    Advancing Pediatric Dermatology: Innovations in Care and Access.

    Pediatric clinics of North America·2026
    Same journal

    No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

    Pediatric clinics of North America·2026
    Same journal

    Telemedicine and Access to Pediatric Dermatology Care.

    Pediatric clinics of North America·2026
    Same journal

    Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

    Pediatric clinics of North America·2026
    Same journal

    Medical Photography's Power to Change Medical Care.

    Pediatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Significant advancements have been made in cancer treatment with the introduction of new chemotherapeutic agents.
    • The development of drugs like cytosine arabinoside and anthracycline antibiotics has expanded treatment options.

    Purpose of the Study:

    • To highlight key breakthroughs in cancer therapy, including combination chemotherapy and central nervous system prophylaxis.
    • To identify current limitations in achieving long-term patient survival.

    Main Methods:

    • Review of established and novel chemotherapeutic agents.
    • Analysis of treatment strategies including combination chemotherapy and prophylactic measures.
    • Evaluation of factors influencing patient survival.

    Main Results:

    Related Experiment Videos

    • Discovery and integration of various drugs (e.g., cytosine arabinoside, anthracyclines, 6-thioguanine, vincristine, cyclophosphamide) into treatment regimens.
    • Major advances include combination chemotherapy, induction of marrow aplasia for remission, and central nervous system prophylaxis.
    • Despite progress, a lack of effective maintenance therapy impedes long-term survival.

    Conclusions:

    • Current therapeutic strategies have led to significant improvements in achieving remission.
    • The primary obstacle to long-term survival is the absence of effective maintenance therapy.
    • Further research into maintenance strategies is crucial for improving patient outcomes.